IFRX InflaRx N.V.

USD 1.14 +0.08 ( +7.55%)
Icon

InflaRx N.V. (IFRX) Financial Statements

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 1.14

+0.08 (+7.55%)

USD 0.06B

0.08M

USD 8.00(+601.75%)

USD 2.00 (+75.44%)

Icon

IFRX

InflaRx N.V. (USD)
COMMON STOCK | NSD
USD 1.14
+0.08 ( +7.55%)

InflaRx N.V. (IFRX) Annual Income Statement (USD)

IFRX Quarterly Financials (USD)

Frequently Asked Questions About InflaRx N.V. (IFRX) Stock

InflaRx N.V.'s (IFRX) last reported annual revenue was USD 165789.00.

InflaRx N.V.'s (IFRX) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A

InflaRx N.V.'s(IFRX) is not profitable as of its last reported annual financials.

The net profit margin for InflaRx N.V.'s(IFRX) from its laster reported year is -27784.96%

The return on equity (ROE) for InflaRx N.V.'s(IFRX) from its last reported annual financials is : -56.18%

The return on assets (ROA) for InflaRx N.V.'s(IFRX) from its last reported annual financials is : -33.77%

The return on invested capital (ROIC) for InflaRx N.V.'s(IFRX) from its last reported annual financials is : -64.62%

The Debt to Equity ratio for InflaRx N.V.'s(IFRX) from its last reported annual financials is : 0.00%

The dividend yield for InflaRx N.V.'s(IFRX) from its laster reported year is 0.00%

InflaRx N.V.'s(IFRX) has negative cash flow as of its last reported annual financials.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...